Insider Transactions in Q2 2021 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,172
+0.38%
|
$33,988
$29.32 P/Share
|
|
Jun 30
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+9.85%
|
$30,276
$29.32 P/Share
|
|
Jun 30
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+9.73%
|
$30,276
$29.32 P/Share
|
|
Jun 30
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,044
+1.24%
|
$30,276
$29.32 P/Share
|
|
Jun 30
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,300
+1.04%
|
$37,700
$29.32 P/Share
|
|
Jun 30
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.24%
|
$6,786
$29.32 P/Share
|
|
Jun 11
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,000
-12.7%
|
$527,000
$31.68 P/Share
|
|
Jun 02
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
121,198
-42.09%
|
$3,757,138
$31.83 P/Share
|
|
Jun 02
2021
|
Christina Ackermann EVP AND GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
121,198
+19.22%
|
$1,696,772
$14.85 P/Share
|
|
Jun 01
2021
|
Sam Eldessouky EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,673
+20.1%
|
-
|
|
May 26
2021
|
Amy B Wechsler Director |
SELL
Open market or private sale
|
Direct |
11,037
-10.09%
|
$342,147
$31.79 P/Share
|
|
Apr 30
2021
|
Richard U De Schutter Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+2.44%
|
-
|
|
Apr 30
2021
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+47.31%
|
-
|
|
Apr 30
2021
|
Sarah B Kavanagh Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+8.43%
|
-
|
|
Apr 30
2021
|
Argeris N Karabelas Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.88%
|
-
|
|
Apr 30
2021
|
Steven D Miller Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+46.95%
|
-
|
|
Apr 30
2021
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+8.52%
|
-
|
|
Apr 30
2021
|
Robert N Power Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.01%
|
-
|
|
Apr 30
2021
|
Russel C Robertson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+5.87%
|
-
|
|
Apr 30
2021
|
Thomas W. Ross Sr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+7.24%
|
-
|
|
Apr 30
2021
|
Andrew C. Von Eschenbach Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+17.03%
|
-
|
|
Apr 30
2021
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+6.53%
|
-
|
|
Apr 30
2021
|
David Robert Hale Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,645
+29.04%
|
-
|